Correction to: Prevalence and predictors of inappropriate apixaban dosing in patients with non‑valvular atrial fibrillation at a large tertiary academic medical institution

Badreldin, Hisham A.; Alreshoud, Lamya; Altoukhi, Renad; Vasudevan, Senthilvel; Ismail, Wesam; Mohamed, Mohamed Salih Aziz

doi:10.1007/s40267-022-00959-x

Correction to: Prevalence and predictors of inappropriate apixaban dosing in patients with non‑valvular atrial fibrillation at a large tertiary academic medical institution

Correction
Published: 31 October 2022

Volume 38, page 499, (2022)
Cite this article

Download PDF

Drugs & Therapy Perspectives Aims and scope Submit manuscript

Correction to: Prevalence and predictors of inappropriate apixaban dosing in patients with non‑valvular atrial fibrillation at a large tertiary academic medical institution

Download PDF

Hisham A. Badreldin ORCID: orcid.org/0000-0001-7182-4347^1,2,3,
Lamya Alreshoud¹,
Renad Altoukhi¹,
Senthilvel Vasudevan^1,3,
Wesam Ismail^1,3 &
…
Mohamed Salih Aziz Mohamed^2,3

1138 Accesses
Explore all metrics

The Original Article was published on 05 December 2019

Use our pre-submission checklist

Avoid common mistakes on your manuscript.

Correction to: Drugs & Therapy Perspectives (2020) 36:83–88 https://doi.org/10.1007/s40267-019-00696-8

The co-author name Wesam Ismail incorrectly published as

Wesam Isamil

It should read as:

Wesam Ismail

The original article has been updated.

Author information

Authors and Affiliations

Pharmacy Practice Department, College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, PO Box 3660, Riyadh, 11481, Saudi Arabia
Hisham A. Badreldin, Lamya Alreshoud, Renad Altoukhi, Senthilvel Vasudevan & Wesam Ismail
King Abdulaziz Medical City, Riyadh, Saudi Arabia
Hisham A. Badreldin & Mohamed Salih Aziz Mohamed
King Abdullah International Medical Research Center, Riyadh, Saudi Arabia
Hisham A. Badreldin, Senthilvel Vasudevan, Wesam Ismail & Mohamed Salih Aziz Mohamed

Authors

Hisham A. Badreldin
View author publications
You can also search for this author in PubMed Google Scholar
Lamya Alreshoud
View author publications
You can also search for this author in PubMed Google Scholar
Renad Altoukhi
View author publications
You can also search for this author in PubMed Google Scholar
Senthilvel Vasudevan
View author publications
You can also search for this author in PubMed Google Scholar
Wesam Ismail
View author publications
You can also search for this author in PubMed Google Scholar
Mohamed Salih Aziz Mohamed
View author publications
You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hisham A. Badreldin.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Badreldin, H.A., Alreshoud, L., Altoukhi, R. et al. Correction to: Prevalence and predictors of inappropriate apixaban dosing in patients with non‑valvular atrial fibrillation at a large tertiary academic medical institution. Drugs Ther Perspect 38, 499 (2022). https://doi.org/10.1007/s40267-022-00959-x

Download citation

Published: 31 October 2022
Issue Date: November 2022
DOI: https://doi.org/10.1007/s40267-022-00959-x

Use our pre-submission checklist

Avoid common mistakes on your manuscript.

Correction to: Prevalence and predictors of inappropriate apixaban dosing in patients with non‑valvular atrial fibrillation at a large tertiary academic medical institution

Correction to: Drugs & Therapy Perspectives (2020) 36:83–88 https://doi.org/10.1007/s40267-019-00696-8

Author information

Authors and Affiliations

Corresponding author

Rights and permissions

About this article

Cite this article

Share this article

Search

Navigation